Abstract
Stroke is the leading cause of long-term disability in the United States and affects more people than any other neurologic disorder. Hypertension is a major risk factor associated with stroke. Several anti-hypertensive agents have been used to treat chronic hypertension to reduce the morbidity and mortality of stroke. Previous experimental studies have shown reduced stroke mortality with angiotensin-converting enzyme (ACE) inhibitors. This review discusses the development of stroke and potential use of ACE inhibitors in prevention and treatment of this disease. Furthermore, this review focuses on current investigations aimed at cellular mechanisms involved in stroke-induced microvascular alterations.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1965-1973 |
| Number of pages | 9 |
| Journal | Peptides |
| Volume | 22 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2000 |
Keywords
- ACE inhibitors
- Cellular mechanisms
- Hypertension
- Hypoxia/reoxygenation
- Stroke
ASJC Scopus subject areas
- Biochemistry
- Physiology
- Endocrinology
- Cellular and Molecular Neuroscience
Fingerprint Dive into the research topics of 'Stroke: Development, prevention and treatment with peptidase inhibitors'. Together they form a unique fingerprint.
Cite this
Mark, K. S., & Davis, T. P. (2000). Stroke: Development, prevention and treatment with peptidase inhibitors. Peptides, 22(12), 1965-1973. https://doi.org/10.1016/S0196-9781(00)00346-6